$10.69
-0.36-3.26%
At close: -
$10.69
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Replimune Group Insider Trading Activity | NASDAQ:REPL | Benzinga
Track the latest Replimune Group insider trading activity. Stay informed on recent buys, sells, and market impact for Replimune Group stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Replimune Group Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Replimune Group Inc
Shares Outstanding
77.015M
Insider Shares Owned
5.189M
Insider Percentage Owned
6.74%
Institutional Shares Held
32.041M
Institutional Percentage Held
41.6%
| Dec 18, 2024 | Sushil Patel | CHIEF EXECUTIVE OFFICER | -10.00K | $12.42 | -$124.20K | SELL | -4.72% | 202.01K | Dec 16 | View |
| Nov 20, 2024 | Konstantinos Xynos | CHIEF MEDICAL OFFICER | -7.25K | $10.78 | -$78.11K | SELL | -6.19% | 109.89K | Nov 18 | View |
| Nov 20, 2024 | Christopher Sarchi | CHIEF COMMERCIAL OFFICER | -5.21K | $10.78 | -$56.13K | SELL | -5.64% | 87.05K | Nov 18 | View |
| Aug 19, 2024 | Luisa Emily Hill | CHIEF FINANCIAL OFFICER | -8.94K | $10.18 | -$90.99K | SELL | -8.13% | 101.06K | Aug 16 | View |
| Jun 10, 2024 | Konstantinos Xynos | CHIEF MEDICAL OFFICER | -15.88K | $7.50 | -$119.11K | SELL | -11.94% | 117.13K | Jun 07 | View |
| May 20, 2024 | Christopher Sarchi | CHIEF COMMERCIAL OFFICER | -2.22K | $6.47 | -$14.35K | SELL | -2.35% | 92.25K | May 16 | View |
| May 20, 2024 | Andrew Schwendenman | CHIEF ACCOUNTING OFFICER | -2.30K | $6.47 | -$14.87K | SELL | -5.67% | 38.24K | May 16 | View |
| May 20, 2024 | Colin Love | CHIEF OPERATING OFFICER | -17.61K | $6.47 | -$113.97K | SELL | -2.22% | 777.35K | May 16 | View |
| May 20, 2024 | Philip AstleySparke | EXECUTIVE CHAIRMAN | -37.93K | $6.47 | -$245.39K | SELL | -2.49% | 1.49M | May 16 | View |
| May 20, 2024 | Robert Coffin | DIRECTOR | -11.46K | $6.47 | -$74.17K | SELL | -0.63% | 1.82M | May 16 | View |
| May 20, 2024 | Sushil Patel | CHIEF EXECUTIVE OFFICER | -20.19K | $6.47 | -$130.66K | SELL | -8.70% | 212.01K | May 16 | View |
| May 20, 2024 | Konstantinos Xynos | CHIEF MEDICAL OFFICER | -6.37K | $6.47 | -$41.19K | SELL | -4.57% | 133.01K | May 16 | View |
| Nov 17, 2023 | Konstantinos Xynos | CHIEF MEDICAL OFFICER | -7.31K | $10.92 | -$79.86K | SELL | -6.09% | 112.71K | Nov 16 | View |
| Nov 17, 2023 | Christopher Sarchi | CHIEF COMMERCIAL OFFICER | -5.25K | $10.92 | -$57.38K | SELL | -6.78% | 72.25K | Nov 16 | View |
| Sep 13, 2023 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0.00 | $11.65 | -$94.54K | SELL-OPTIONS | 0.00% | 263.44K | Sep 11 - Sep 12 | View |
| Aug 24, 2023 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0.00 | $13.29 | -$249.81K | SELL-OPTIONS | 0.00% | 263.44K | Aug 22 | View |
| Aug 15, 2023 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0.00 | $11.65 | -$23.38K | SELL-OPTIONS | 0.00% | 263.44K | Aug 11 | View |
| Jul 11, 2023 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0.00 | $13.96 | -$304.54K | SELL-OPTIONS | 0.00% | 263.44K | Jul 10 | View |
| Jun 15, 2023 | Tanya Lewis | CHIEF DEV. OP. OFFICER | -12.86K | $24.06 | -$309.39K | SELL | -8.68% | 135.29K | Jun 13 | View |
| Jun 15, 2023 | Sushil Patel | CHIEF STRATEGY OFFICER | -5.70K | $24.04 | -$137.01K | SELL | -3.69% | 148.87K | Jun 13 | View |
| May 18, 2023 | Sushil Patel | CHIEF STRATEGY OFFICER | -15.57K | $18.05 | -$281.13K | SELL | -9.15% | 154.57K | May 16 | View |
| May 18, 2023 | Robert Coffin | PRESIDENT & CHIEF R&D OFFICER | -7.86K | $18.05 | -$141.89K | SELL | -0.43% | 1.83M | May 16 | View |
| May 18, 2023 | Tanya Lewis | CHIEF DEV. OP. OFFICER | -12.21K | $18.05 | -$220.34K | SELL | -7.61% | 148.15K | May 16 | View |
| May 18, 2023 | Colin Love | CHIEF OPERATING OFFICER | -10.78K | $18.05 | -$194.49K | SELL | -1.34% | 794.96K | May 16 | View |
| May 18, 2023 | Jean Franchi | CHIEF FINANCIAL OFFICER | -11.35K | $18.05 | -$204.89K | SELL | -8.10% | 128.75K | May 16 | View |
| May 18, 2023 | Konstantinos Xynos | CHIEF MEDICAL OFFICER | -771.00 | $18.05 | -$13.92K | SELL | -0.64% | 120.03K | May 16 | View |
| May 18, 2023 | Pamela Esposito | CHIEF BUSINESS OFFICER | -5.97K | $18.05 | -$107.69K | SELL | -2.21% | 263.44K | May 16 | View |
| May 18, 2023 | Philip AstleySparke | CHIEF EXECUTIVE OFFICER | -17.90K | $18.05 | -$323.13K | SELL | -1.16% | 1.53M | May 16 | View |
| Dec 13, 2022 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0.00 | $13.02 | -$360.30K | SELL-OPTIONS | 0.00% | 229.40K | Dec 09 | View |
| May 18, 2022 | Colin Love | CHIEF OPERATING OFFICER | -6.32K | $14.59 | -$92.27K | SELL | -0.82% | 765.74K | May 16 | View |
| May 18, 2022 | Pamela Esposito | CHIEF BUSINESS OFFICER | -3.51K | $14.59 | -$51.17K | SELL | -1.51% | 229.40K | May 16 | View |
| May 18, 2022 | Jean Franchi | CHIEF FINANCIAL OFFICER | -3.44K | $14.59 | -$50.13K | SELL | -3.49% | 95.10K | May 16 | View |
| May 18, 2022 | Tanya Lewis | CHIEF DEV. OP OFFICER | -5.47K | $14.59 | -$79.85K | SELL | -4.35% | 120.36K | May 16 | View |
| May 18, 2022 | Sushil Patel | CHIEF COMMERCIAL OFFICER | -10.69K | $14.59 | -$155.92K | SELL | -7.59% | 130.15K | May 16 | View |
| May 18, 2022 | Robert Coffin | PRESIDENT & CHIEF R&D OFFICER | -5.74K | $14.59 | -$83.70K | SELL | -0.32% | 1.80M | May 16 | View |
| May 18, 2022 | Philip AstleySparke | CHIEF EXECUTIVE OFFICER | -9.63K | $14.59 | -$140.53K | SELL | -0.68% | 1.40M | May 16 | View |
| Mar 16, 2022 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | 10% OWNER | -90.00K | $12.67 | -$1.50M | SELL | -1.89% | 4.67M | Mar 14 - Mar 16 | View |
| Nov 23, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -45.42K | $34.58 | -$1.57M | SELL | -0.94% | 4.76M | Nov 19 - Nov 22 | View |
| Nov 18, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -2.59K | $33.50 | -$86.90K | SELL | -0.05% | 4.81M | Nov 16 - Nov 18 | View |
| Nov 18, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -2.59K | $33.50 | -$86.90K | SELL | -0.05% | 4.81M | Nov 16 - Nov 18 | View |
| Nov 16, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -24.02K | $33.66 | -$808.41K | SELL | -0.50% | 4.81M | Nov 12 - Nov 15 | View |
| Nov 12, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -18.29K | $33.61 | -$614.73K | SELL | -0.38% | 4.84M | Nov 10 - Nov 11 | View |
| Nov 10, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -11.35K | $33.66 | -$382.21K | SELL | -0.23% | 4.85M | Nov 08 - Nov 09 | View |
| Nov 08, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -31.02K | $33.57 | -$1.04M | SELL | -0.63% | 4.87M | Nov 04 - Nov 05 | View |
| Oct 19, 2021 | Colin Love | CHIEF OPERATING OFFICER | -30.00K | $30.06 | -$901.89K | SELL | -3.87% | 745.81K | Oct 15 - Oct 18 | View |
| Sep 27, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -12.17K | $33.58 | -$408.70K | SELL | -0.25% | 4.90M | Sep 23 | View |
| Sep 20, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -100.00K | $32.99 | -$3.30M | SELL | -2.00% | 4.91M | Sep 16 - Sep 17 | View |
| Sep 17, 2021 | Colin Love | CHIEF OPERATING OFFICER | -30.00K | $31.23 | -$936.90K | SELL | -3.72% | 775.81K | Sep 15 | View |
| Aug 18, 2021 | Colin Love | CHIEF OPERATING OFFICER | -30.00K | $29.93 | -$898.03K | SELL | -3.59% | 805.81K | Aug 16 | View |
| Aug 06, 2021 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0.00 | $25.29 | -$587.32K | SELL-OPTIONS | 0.00% | 210.16K | Aug 04 - Aug 05 | View |
| Jul 22, 2021 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0.00 | $17.07 | -$559.00K | SELL-OPTIONS | 0.00% | 210.16K | Jul 20 - Jul 21 | View |
| Jul 19, 2021 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0.00 | $17.19 | -$148.86K | SELL-OPTIONS | 0.00% | 210.16K | Jul 15 | View |
| Jul 16, 2021 | Colin Love | CHIEF OPERATING OFFICER | -30.00K | $32.02 | -$960.60K | SELL | -3.46% | 835.81K | Jul 15 | View |
| Jul 07, 2021 | Robert Coffin | PRESIDENT & CHIEF R&D OFFICER | -7.81K | $40.04 | -$312.71K | SELL | -0.44% | 1.78M | Jul 02 | View |
| Jun 30, 2021 | Robert Coffin | PRESIDENT & CHIEF R&D OFFICER | -37.49K | $40.05 | -$1.50M | SELL | -2.06% | 1.78M | Jun 28 - Jun 29 | View |
| Jun 16, 2021 | Colin Love | CHIEF OPERATING OFFICER | -30.00K | $34.10 | -$1.02M | SELL | -3.35% | 865.81K | Jun 15 | View |
| Apr 19, 2021 | Colin Love | CHIEF OPERATING OFFICER | -30.00K | $30.63 | -$918.78K | SELL | -3.24% | 895.81K | Apr 15 | View |
| Mar 17, 2021 | Colin Love | CHIEF OPERATING OFFICER | -30.00K | $33.54 | -$1.01M | SELL | -3.27% | 886.52K | Mar 15 | View |
| Feb 18, 2021 | Colin Love | CHIEF OPERATING OFFICER | -30.00K | $36.32 | -$1.09M | SELL | -3.17% | 916.52K | Feb 16 | View |
| Feb 11, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -5.25K | $45.00 | -$236.21K | SELL | -0.10% | 5.14M | Feb 08 | View |
| Jan 28, 2021 | Jason Rhodes | DIRECTOR | -5.56K | $46.14 | -$256.45K | SELL | -0.57% | 965.28K | Jan 26 | View |
| Jan 28, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -30.35K | $45.42 | -$1.38M | SELL | -0.57% | 5.28M | Jan 26 | View |
| Jan 26, 2021 | Robert Coffin | PRESIDENT & CHIEF R&D OFFICER | -60.00K | $44.43 | -$2.67M | SELL | -3.33% | 1.74M | Jan 22 | View |
| Jan 26, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -11.36K | $45.04 | -$511.66K | SELL | -0.21% | 5.31M | Jan 22 | View |
| Jan 19, 2021 | Philip AstleySparke | CHIEF EXECUTIVE OFFICER | -50.00K | $43.76 | -$2.19M | SELL | -3.83% | 1.26M | Jan 14 - Jan 19 | View |
| Jan 19, 2021 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0.00 | $22.50 | -$2.36M | SELL-OPTIONS | 0.00% | 175.99K | Jan 14 - Jan 19 | View |
| Jan 19, 2021 | Colin Love | CHIEF OPERATING OFFICER | -30.00K | $43.24 | -$1.30M | SELL | -3.07% | 946.52K | Jan 15 - Jan 19 | View |
| Jan 19, 2021 | Omega Fund IV LPOmega Fund IV GP LPOmega Fund IV GP Manager LtdOtello Stampacchia | DIRECTOR | -19.58K | $45.10 | -$883.05K | SELL | -0.37% | 5.33M | Jan 14 - Jan 15 | View |
| Jan 15, 2021 | Jean Franchi | CHIEF FINANCIAL OFFICER | 0.00 | $29.30 | -$456.68K | SELL-OPTIONS | 0.00% | 0.00 | Jan 13 - Jan 14 | View |
| Dec 28, 2020 | Robert Coffin | — | -220.00K | $40.04 | -$8.81M | SELL | -10.87% | 1.80M | Dec 22 | View |
| Dec 22, 2020 | Jason Rhodes | — | -4.32K | $41.95 | -$181.18K | SELL | -18.30% | 19.29K | Dec 18 | View |
| Dec 17, 2020 | Jason Rhodes | — | -65.03K | $42.28 | -$2.75M | SELL | -76.89% | 19.55K | Dec 15 - Dec 17 | View |
| Dec 16, 2020 | Jean Franchi | — | 0.00 | $28.76 | -$734.20K | OPTION EXERCISE | 0.00% | 0.00 | Dec 14 | View |
| Dec 14, 2020 | Jason Rhodes | — | -103.69K | $43.35 | -$4.49M | SELL | -81.54% | 23.48K | Dec 10 - Dec 14 | View |
| Dec 11, 2020 | Philip AstleySparke | — | -50.00K | $43.40 | -$2.17M | SELL | -3.69% | 1.31M | Dec 09 - Dec 10 | View |
| Dec 11, 2020 | Colin Love | — | -30.00K | $43.75 | -$1.31M | SELL | -2.98% | 976.52K | Dec 09 | View |
| Dec 09, 2020 | Jason Rhodes | — | -217.36K | $45.92 | -$9.98M | SELL | -87.96% | 29.75K | Dec 07 - Dec 09 | View |
| Dec 09, 2020 | JOSEPH SLATTERY | — | 0.00 | $24.65 | -$222.04K | OPTION EXERCISE | 0.00% | 6.67K | Dec 08 | View |
| Dec 09, 2020 | Kapil Dhingra | — | 0.00 | $23.65 | -$1.75M | OPTION EXERCISE | 0.00% | 0.00 | Dec 07 | View |
| Nov 18, 2020 | Colin Love | — | -15.00K | $44.91 | -$673.65K | SELL | -1.47% | 1.01M | Nov 16 | View |
| Oct 16, 2020 | Pamela Esposito | — | 0.00 | $16.96 | -$510.25K | OPTION EXERCISE | 0.00% | 112.70K | Oct 14 | View |
| Sep 17, 2020 | Colin Love | — | -15.00K | $23.97 | -$359.49K | SELL | -1.45% | 1.02M | Sep 15 | View |
| Sep 01, 2020 | Pamela Esposito | — | 0.00 | $14.03 | -$130.20K | OPTION EXERCISE | 0.00% | 112.70K | Aug 31 | View |
| Aug 18, 2020 | Colin Love | — | -15.00K | $23.44 | -$351.55K | SELL | -1.43% | 1.04M | Aug 17 | View |
| Jul 10, 2020 | Robert Coffin | — | -169.75K | $22.13 | -$3.76M | SELL | -7.74% | 2.02M | Jul 09 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.